Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CCXI $5.20 0.7800 +17.65%
STML $7.81 1.0200 +15.02%
OMED $14.62 1.0400 +7.66%
ARGS $5.96 0.4000 +7.19%
TGTX $7.73 0.5100 +7.06%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

VRML $1.21 -0.0900 -6.92%
GTXI $0.72 -0.0300 -4.00%
TKMR $4.10 -0.1600 -3.76%
MACK $6.31 -0.2300 -3.52%
IMDZ $12.56 -0.3800 -2.94%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

Could Space Research Offer New Hope For Cancer Patients?

( May 16, 2016 - The nano age and space age have converged in a partnership that could usher in a new era of hope for cancer patients.
read article 

Biden Takes Stage At DC DataPalooza Event To Talk About His Moonshot On Cancer

(Forbes) May 16, 2016 - The Vice President was adamant about the need to break down silos in health care. He pleaded for there to be an open national network of cancer registries and databases.
read article 

Oncologists Break Old Rules With Precision Cancer Treatments

(NPR/All Things Considered) May 13, 2016 - NPR's Robert Siegel talks to physician and author Siddhartha Mukherjee about how the fight against cancer has changed so dramatically in this era of precisely targeted treatments.
read article 

Big Data Can Save Lives, Says Leading Queen's University Cancer Expert

(Queen's University Belfast) May 16, 2016 - The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
read article 

Raising The Survival Bar, And Access To Information, On Metastatic Cancer

(Forbes) May 13, 2016 - The public has every right to current information, on what’s known about survival after a diagnosis of metastatic breast cancer, and for all forms of cancer.
read article 

Cancer Charities In Desperate Plea To Cameron Over Drugs Rationing Plan

(The Telegraph [UK]) May 15, 2016 - Leading cancer experts have pleaded with the Prime Minister to prevent NHS plans which they say could deny life-extending drugs to thousands of dying patients.
read article 

Roche Moves Court To Block Copies Of Cancer Drug Avastin, A La Herceptin

(The Economic Times [Mumbai, India]) May 16, 2016 - Swiss biotechnology giant Roche has sued the Drug Controller General of India in Delhi High Court along with Hyderabad-based Hetero Drugs over the process followed for approval of copies of complex biotech drugs or biosimilars of Avastin (bevacizumab), its blockbuster brand that is used to treat at least six forms of advanced cancers.
read article 

Counterfeit Version of BiCNU Discovered in Some Foreign Countries

(ASCO in Action) May 16, 2016 - On May 13, the Food and Drug Administration (FDA) posted information on its website informing health care professionals that a counterfeit version of the FDA approved cancer drug, BiCNU (carmustine for injection) 100 mg, has been detected in some foreign countries.
read article 

Untreated Sleep Apnea May Be Related to Melanoma Aggressiveness

(ATS 2016) May 16, 2016 - Untreated severe obstructive sleep apnea (OSA) is associated with increased aggressiveness of malignant cutaneous melanoma, according to the first multicenter prospective study on the relationship between sleep-disordered breathing (apnea or hypopnea) and cancer.
read press release 

NeOnc Technologies Announces Initiation of Phase 1/2a Clinical Trial of NEO100™ in Recurrent Glioblastoma Multiforme (GBM)

(4-traders) May 14, 2016 - NeOnc Technologies, Inc., a privately held biotechnology company today announced the initiation of its multi-center Phase 1/2a clinical trial of NEO100 with the first patient being treated at the Cleveland Clinic.
read article 

Chi-Med Completes Enrollment of 416 Patients in Pivotal Phase III FRESCO Trial with Fruquintinib in Colorectal Cancer

(Yahoo! Finance) May 13, 2016 - Hutchison China MediTech Limited today announces that it has completed patient enrollment of FRESCO, its Phase III pivotal trial of fruquintinib (HMPL-013) in third-line locally advanced or metastatic colorectal cancer in China, where an estimated 390,000 new cases of CRC were diagnosed in 2012.
read article 

New KEYTRUDA® (pembrolizumab) Data at 2016 ASCO Annual Meeting Includes Three-Year Overall Survival Data in Melanoma and Updated Overall Survival Data in Non-Small Cell Lung Cancer As Well As Updated Findings in Head and Neck Cancer

(Merck) May 16, 2016 - Data at ASCO evaluates KEYTRUDA as single agent and in novel combinations in more than 15 different cancers, including several new tumors.
read corporate press release 

Genetic Biomarker May Predict Nerve Pain Side Effects Associated With Prostate Cancer Treatment

(Moffitt Cancer Center) May 12, 2016 - New study finds genetic alterations in the VAC14 gene are associated with an increased risk of docetaxel-induced peripheral neuropathy in prostate cancer patients.
read press release 

Increased Physical Activity Associated with Lower Risk of 13 Types of Cancer

(NCI) May 16, 2016 - A new study of the relationship between physical activity and cancer has shown that greater levels of leisure-time physical activity were associated with a lower risk of developing 13 different types of cancer.
read press release 

Man Receives First Penis Transplant in the United States

(New York Times) May 16, 2016 - A man whose penis was removed because of cancer has received the first penis transplant in the United States, at Massachusetts General Hospital in Boston.
read article 

Lenvatinib in Combination with Everolimus

( May 16, 2016 - On May 13, 2016, the U. S. Food and Drug Administration approved lenvatinib capsules (Lenvima, Eisai, Inc.), in combination with everolimus, for the treatment of advanced renal cell carcinoma following one prior anti-angiogenic therapy.
read article 

Aduro Biotech Pancreatic Cancer Immunotherapy Fails Mid-Stage Study

(TheStreet) May 16, 2016 - A type of common bacteria re-engineered by Aduro Biotech to engage the immune system to kill pancreatic cancer failed a mid-stage study, the company announced Monday.
read article 

FDA Approves Eisai's LENVIMA (lenvatinib) for the Treatment of Patients with Advanced Renal Cell Carcinoma in Combination with Everolimus Following Prior Anti-Angiogenic Therapy

(Eisai) May 13, 2016 - Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) approved LENVIMA®(lenvatinib), the company's multiple receptor tyrosine kinase inhibitor, in combination with everolimus for the treatment of patients with advanced renal cell carcinoma (aRCC) who were previously treated with an anti-angiogenic therapy.
read corporate press release 

Cancer Patient Receives First Penis Transplant in US

(ABC News/Associated Press) May 16, 2016 - A cancer patient has received the first penis transplant in the United States, a Boston hospital said Monday.
read article 

American Cancer Society Report Assesses Progress against Goals Set for Nation

(ACS) May 13, 2016 - A new report assesses how the nation fared against the ambitious challenge goal set by the American Cancer Society to reduce the cancer death rates by 50% over 25 years ending in 2015.
read press release 

Hospitals, Insurers Drop on Ruling Against Obamacare Funding

(Bloomberg) May 12, 2016 - Hospital and insurer stocks dropped after a federal judge in Washington ruled that some of the funding for President Barack Obama’s signature health-care law is unconstitutional, potentially jeopardizing a source of their revenue.
read article 

Regeneron CEO Says Drug Price Critique by Independent Group Unscientific

(Reuters) May 12, 2016 - Regeneron Pharmaceuticals Chief Executive Leonard Schleifer on Thursday took aim at an influential drug pricing watchdog, saying a critique of the company's new cholesterol lowering therapy was non-scientific.
read article 

Finding Value-Based Payment Measures That Work

(MedPage Today) May 12, 2016 - Physicians and other health policy experts explored the challenges of getting value-based payment right at a briefing hosted by Health Affairs on Thursday.
read article (free registration required) 

Experts Decry Tying Medical Research Funds to FDA Standards Changes

(Wall Street Journal) May 12, 2016 - Moves in Congress to link billions of dollars in new medical research funding to revised standards for drug and medical-device approvals are troubling some public-health experts, who say the combination makes it too easy for lawmakers to support lower patient-safety standards.
read article (paid subscription required) 

Leading Surgical Oncology Societies Call for Global Curriculum to Address Variations, Inadequacies in Training

(ECCO) May 12, 2016 - The lack of an adequately trained workforce of surgical oncologists can be a major detriment in efforts to address the rising global cancer burden, according to two leading international surgical oncology societies.
read press release